Arteriosclerosis Thrombosis and Vascular Biology Impact Factor, Indexing, Ranking 2024

Arteriosclerosis, Thrombosis, and Vascular Biology  (ATVB) publishes laboratory-based, translational, clinical and population research that is related to cardiovascular, peripheral vascular and cerebrovascular biology and disease. Areas of focus include atherosclerosis, lipid biology, arterial stiffening, thrombosis and hemostasis, and vascular and valvular biology. ATVB encourages submissions that use state-of-the-art approaches to illuminate mechanisms of disease and uncover new therapies and biomarkers through experimentation in animal and cellular models and in humans. The journal values novel technological developments—such as in bioengineering and with ‘omics platforms.ATVB maintains the highest standards of methodological and statistical rigor, prioritizes engagement with the research community (readers, authors, AHA/ATVB members, and our Early Career Editorial Board mentees) and publishes original research as well as scientific statements, viewpoints, opinions and consortium papers. Through dissemination of the highest quality research, ATVB supports the overall mission of the American Heart Association: to promote longer and healthier lives.

《动脉粥样硬化、血栓形成与血管生物学》（ATVB）杂志专注于发表基于实验室、转化性、临床及人群研究的成果，这些研究涉及心血管、周围血管及脑血管的生物学和疾病。该杂志聚焦的领域包括动脉粥样硬化、脂质生物学、动脉硬化、血栓形成与止血，以及血管与瓣膜生物学。ATVB 鼓励采用最前沿的方法，通过动物和细胞模型以及人体实验来阐明疾病机制，并揭示新的治疗方法和生物标志物。该杂志重视新颖的技术发展，如生物工程学与‘组学’平台。ATVB 坚持最高的方法论和统计学严谨性标准，优先考虑与科研界（读者、作者、美国心脏协会/ATVB 成员以及我们的早期职业编辑委员会的指导学员）的互动，并发表原创研究以及科学声明、观点、评论和共识论文。通过传播最高质量的研究成果，ATVB 支持美国心脏协会的整体使命：促进人们更长寿、更健康的生活。